---
title: Sevoflurane
date: '2022-12-02'
type: page
weight: 1500
commentable: true
show_breadcrumb: true
tags:
- sevoflurane
authors:
    - Justin Hefley
    - Lauren Suszan
---

#### MAC: **2**
#### Blood-Gas: **0.65**
#### % Metabolism: **2 - 5**
#### Vapor Pressure: **160**

{{% notice style="info" title="Relative MAC Values" %}}
 | MAC-BAR   |    ED95    |    MAC-Awake    |    MAC-Aware|
 | :-------:| :----------: | :-----------: | :--------------: |
 | 1.5 | 1.3 | 0.4 | 0.5 |
{{% /notice %}}

- {{% notice style="red" %}}MH Trigger{{% /notice %}}
- Potent inhalational Anesthetic
- ↑ RR
- ↓ TV & MV
- ↑ bronchodilation
- Dose-dependent depression of the ventilatory response to hypercarbia & hypoxia
- ↓ ciliary movement and altered mucous characteristics
- Dose-dependent effect on skeletal muscle relaxation (most prominent > 1 MAC)
- Potentiates the action of neuromuscular blockers (enhanced by 40% in patients with myasthenia gravis)
- In the presence of a dessicated CO2 absorber, exothermic reaction with volatile anesthetics can lead to fire and/or carbon monoxide formation (less so than Isoflurand and Desflurane)
- Desflurane > Isoflurane >> Sevoflurane
- Breaks down in the CO₂ absorber to compound A.  To mitigate this risk flows can be 1-2 lpm for up to 2 MAC hours then > 2 lpm
- Most highly metabolized modern inhalational anesthetic.  
- Metabolized into flouride ions which can be nephrotoxic (not shown to be clinically significant)
- All MAC doses can be decreased by co-administered agents (benzodiazepines, opioids, Alpha2 agonists, etc.)